AMPLY DISCOVERY EXPLAINS HOW ITS AI TECHNOLOGY CAN IDENTIFY NOVEL BIOLGICAL DRUG CANDITATES

CEO, Ben Thomas, and CCO, Dermot Tierney, joined Moira Gunn from BioTech Nation to discuss exactly why the company was formed and how, with the assistance of AI and machine learning, it’s technology can identify novel biological drug and nutraceutical candidates

Click here to listen.

Podcast taken from: https://www.biotechnation.com/episodes/why-do-ai-one-way-when-you-can-do-it-25-dr-ben-thomas-and-dermot-tierny-ceo-cco-amply-discovery

Share the Post:

Related Posts

Investment Fund for Northern Ireland passes the £100m milestone

The British Business Bank has announced

the Investment Fund for Northern Ireland has surpassed £100 million in total investment, marking 75 investments into 64 businesses since launching in November 2023. The fund has deployed more than £44 million to date, helping unlock in excess of £62 million in private sector investment alongside it.

Read More